Biosciences investing resistant – but not immune – to global markets’ illnesses

November 25, 2008 | Analyst Insight

Even in a recession, people get sick and need treatment, which is why biotech and pharmaceutical stocks have been seen as a relatively safe haven during the global financial crisis; life sciences...